Lonza Shares Rise on Sales, Earnings Beat
By David Sachs
Lonza shares jumped Friday after the company posted consensus-beating sales and earnings.
At 0858 GMT, shares in the Swiss life-sciences company were up 13% at CHF419.30 after rising as high as CHF420.90.
Lonza's full-year sales of 6.72 billion Swiss francs ($7.75 billion) were 3% above the company-compiled consensus, while core earnings before interest, taxes, depreciation and amortization were 5% ahead at CHF2.00 billion, Jefferies analysts said in a note.
Jefferies said the stronger second half of last year should offset negative currency affects and could trigger small consensus updates, which is better than the downside risk feared by the analysts.
Lonza also nominated Jean-Marc Huet to replace Albert Baehny as chairman, but the move shouldn't disrupt the group's crucial search for a new chief executive, Jefferies said.
Write to David Sachs at david.sachs@wsj.com
(END) Dow Jones Newswires
January 26, 2024 04:23 ET (09:23 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations